Cytotoxicity of ochratoxin A (OTA) was evaluated using the MTS assay, and membrane integrity was measured using transepithelial electrical resistance (TEER). A transwell system was used to investigate the effect of OTA on the expression of the CYP450 (1A1, 2A6, 2B6, 3A4 and 3A5), NAT2, COX-2, LOX-5, and MRP2 genes in Caco-2 and HepG2 cells. TEER decreased by a mean of 63.2% after 24 h in Caco-2 differentiated cells without inducing cell detachment; revealing damage to the intestinal epithelial cell tight junction proteins and an increase in cell permeability. Gene expression analysis showed that modulation of gene expression by OTA was higher in Caco-2 cells than in HepG2 cells, and generally, the duration of exposure to OTA had a more significant effect than the OTA dose. A general OTA down-regulation effect was observed in Caco-2 cells, in contrast with the down-and up-regulation observed in HepG2 cells. In Caco-2 cells, CYP1A1 was the gene with the highest regulation, followed by CYP3A4 and CYP3A5.
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Introduction
Ochratoxin A (OTA) is a mycotoxin produced by some species of two ubiquitous genera of fungi, Aspergillus and Penicillium. This mycotoxin is frequently found in a wide variety of raw materials (such as cereals and fruits) and foodstuffs (coffee, beer, wine, cocoa products, and grape juice) (EFSA, 2006) . It can also be found in foods of an animal origin due to its bioaccumulation in tissues, even in the case of animals sub-chronically exposed to OTA (Perši et al., 2014) . The presence of OTA in feed has been linked to the development of nephrotoxicity, which, in rats, has been associated with renal adenomas and kidney tumours (Boorman, 1989; IARC, 1993) . Several mechanisms of OTA toxicity have been described, including competition with phenylalanine for protein synthesis, inhibition of mitochondrial ATP production, production of free radicals, promotion of lipid peroxidation, and direct and indirect damage to DNA (El Khoury and Atoui, 2010; González-Arias et al., 2014; Ringot et al., 2006) .
OTA is absorbed in the intestine, where the multi-drug resistance protein 2 (MRP2 gene) plays an important role acting as a xenobiotic outward transporter to reduce the oral bioavailability and the toxin load to organs and, thereby, OTA toxicity (Berger et al., 2003; Dietrich et al., 2003) . Once OTA reaches the bloodstream, it can reach other organs such as the liver, and the MRP2 transporter is again a key primary active transporter involved in anionic conjugate and drug/xenobiotic extrusion into the extracellular space, which contributes to bile formation and the subsequent elimination of the toxin (Dietrich et al., 2003; Jedlitschky et al., 2006) . 2 The inactivation or bioactivation of the OTA molecule via the cytochrome P450 system has been described as a key factor in relation to the in vitro and in vivo OTA toxicity.
For example, Zepnil et al. (2001) showed that OTA oxidation was mediated by the CYP450 enzymes in in vitro reactions with microsomes of liver and kidney from Wistar rats. On the other hand, Pfohl-Leszkowicz et al. (2012) have demonstrated the formation of OTA-derived DNA adducts and mutations and the involvement of the CYP450 enzymes in the bioactivation of OTA. The presence of DNA double-strand breaks and the micronucleus formation observed in in vivo or in vitro assays with cells capable of expressing cytochrome P450 (CYP450) enzymes support the OTA genotoxicity (González-Arias et al., 2014; Groene et al., 1996; Hibi et al., 2013) .
Little is known about the involvement of human N-acetyltransferase 2 (NAT2), a phase II enzyme encoded by the NAT2 gene. NAT2 shows a restricted tissue distribution, and high levels are found in the human liver and intestine. Lack of NAT2 function is associated with higher incidences of cancer and drug toxicity (Husain et al., 2007) . To our knowledge, the study of Lebrun et al. (2002) is the only one that has analysed the involvement of NAT2 in OTA genotoxicity. The authors observed a positive correlation between DNA damage and NAT2 polymorphisms in human urothelial cells exposed to OTA.
Regarding the cyclooxygenase-2 (COX-2) and lipoxygenase-5 (5-LOX) genes, some in vitro and in vivo assays indicate that the over expression of these genes is related to cancer initiation or chronic inflammation processes in a variety of cancers in humans. For this reason, both genes have been described as inflammatory mediators (González-3 Périz and Clàira, 2007; Terzic et al., 2010) , but the modulation of these genes by OTA is still poorly studied (Ferrante et al., 2006; Kumar et al., 2013; Ramyaa et al., 2014) .
The present study aimed to investigate the effect of OTA on expression of five genes from the CYP450 family (CYP1A1, CYP2A6, CYP2B6, CYP3A4 and CYP3A5), as well as expression of the NAT2, COX-2, 5-LOX and MRP2 genes. Although the involvement of the CYP450 enzymes is well known in OTA biotransformation, much less is known about the role of COX-2, 5-LOX and NAT2 and the effect of OTA in the modulation of expression of these genes. Considering that OTA is a mycotoxin that mainly enters the human body via ingestion, we have used an in vitro cell co-culture system to mimic initial passage through the intestine and hepatic metabolism, using two human cell lines. Caco-2 cell line is a well established in vitro model especially indicated to study intestinal absorption, metabolism, and bioavailability of drugs and xenobiotics (Artursson et al., 2001; Natoli et al., 2011) . On the other hand, the use of human liver cells, as the HepG2 cell line, in the co-culture system tries to simulate the place where the main xenobiotic metabolism occurs in humans.
Methodology
Reagents and instrumentations
The following products were obtained from Sigma-Aldrich (Steinheim, Germany): OTA 
Cell culture
The human colon cell line Caco-2 (HTB-37) and the hepatic cell line HepG2 were obtained from the American Type Culture Collection (ATCC). Cells were grown as monolayer cultures in 75 cm 2 flasks and maintained with DMEM in an atmosphere at 95% relative humidity and 5% CO2 at 37 °C. DMEM was supplemented with foetal bovine serum (15% v/v for Caco-2 or 10% v/v for HepG2 cells), 1% (v/v) of non-essential amino acids, 1% (v/v) of L-glutamine and 1% (v/v) of an antibiotic mixture (penicillin and streptomycin). Cellular monolayers (80% confluence) were detached with a solution of trypsin-EDTA, and the cells were reseeded to carry out the cytotoxicity assay or the co-5 culture system. Caco-2 and HepG2 cells were used at passages from 33 to 42 and from 15 to 25, respectively.
Cytotoxic assays
MTS assay
HepG2 cells were reseeded in 96-well plates at a density of 1.5 x 10 5 cells/cm 2 , and Caco-2 cells were reseeded at a density of 10 5 cells/cm 2 , allowing 24 h for cell adherence. Cell viability was determined using a stable solution of MTS from the Immediately, 100 μL of culture medium with 317 μg/mL MTS-one solution was added per well. Cells were incubated for 2.5 h (Caco-2) or 2 h (HepG2). Optical density was determined using a 96-plate reader (DAS-A3, Roma, Italy) with a 490 nm filter (FGF2, TSP1). Relative cell viability was expressed as a percentage with respect to the cells in the solvent control treatment.
Transepithelial electrical resistance (TEER) measurement
The maintenance of cell monolayers was performed as described in the co-culture section. The TEER value of all of the Caco-2 cell monolayers was recorded at day 21 (before treatments) to determine the effect of OTA on membrane integrity as a Resistanceblank is considered as the value of the resistance of a filter without cells.
Caco-2/HepG2 co-culture system
Caco-2 differentiation
Caco-2 cells were reseeded at 10 5 cells/cm 2 on polycarbonate membrane inserts in 6-transwell plates and maintained for 21 days with complete medium. The TEER increment was monitored at 9, 15 and 20 days (3 wells for each experiment) as a signal of progression of cell differentiation. The TEER increase (mean ± DS) was in the range of 240 ± 20 to 500 ± 35 Ω•cm 2 .
Co-culture system and OTA treatments
The transwell permeable supports were used for transepithelial electrical resistance (TEER) and the gene expression studies. HepG2 cells were seeded in 6-well plates at a density of 1.5 x 10 5 cells/cm 2 (at day 20 of the Caco-2 cells differentiated monolayers).
Twenty-four hours after the seeding of HepG2 cells, the co-cultures were performed (Day 21). Non-cytotoxic doses (5, 15 and 45 μM) of OTA were selected for 3, 12 and 24 h treatments in transwell plates. The treatments were carried out in culture medium, and 7 the percentage of solvent (DMSO) in the treatments was 0.05% of the final volume in the transwell system for all of the treatments.
Gene expression
RNA extraction and cDNA synthesis
Total RNA was prepared from freshly isolated cells using the Trizol® reagent, according to the manufacturer´s protocol. RNA integrity was checked on an agarose gel stained with ethidium bromide (EtBr). The concentration and purity of total RNA were determined by measuring the ratio of absorbance at 260/280 nm and 260/230 nm in a NanoDrop ND-1000 (Thermo Scientific, USA), respectively. 5 µg of total RNA was treated with TURBO TM DNase to remove contaminating genomic DNA. The SuperScript TM III reverse transcriptase kit and a Oligo(dT) primer were used to synthesize first-strand cDNA.
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
Primers used in this study are listed in Table 1 . The primer set used for amplifying the CYP2A6 gene was designed with OLIGO Primer Analysis Software V.7. Real-time RTqPCR reactions were performed in a CFX96 Touch™ Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA, USA) monitoring cDNA amplification with iTaqTM Universal SYBR® green Supermix (Bio-Rad Laboratories, Hercules, CA, USA). The program included one cycle at 95 ºC for 2 minutes followed by 40 cycles of 15 s at 95 ºC and 30 s at 58 ºC and, finally, a dissociation and amplification curve step to check the PCR reaction quality.
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To validate the RT-qPCR, a standard curve was generated with 6 set points of two-fold serial cDNA dilutions. A pool of cDNA from Caco-2 or HepG2 cells was used to run the standard curve. The standard curve was generated by plotting the quantification cycle (Cq) versus the logarithmic value of the cDNA concentration. The real-time PCR efficiency (E) of one cycle in the exponential phase was calculated for each primer pair (equation 2), where the slope belongs to the standard curve (Rasmussen, 2001 ).
Expression level was normalized using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA. The relative expression ratio (r) of the genes was calculated according to the 2 -ΔΔCp mathematical model, based on E and the Cq deviation (equation 3) (Pfaffl, 2001 ).
ΔCqtarget is the subtraction of Cqcontrol from the Cqsample for the target gene, and
ΔCqreference is the subtraction of Cqcontrol from the Cqsample for the reference gene.
[Insert Table 1 Statistical analyses were conducted using Statgraphics plus. Cell viability, membrane integrity and gene expression were analysed using ANOVA and the Bonferroni post-test.
p-values < 0.05 were considered to be statistically significant.
Results
Cytotoxic assays
MTS assay
The increase of OTA concentration (from 1 to 180 µM) resulted in a significant decrease of cell viability in both cell types, at the three exposure times assayed (Table 2) [Insert 
Gene expression
To elucidate OTA metabolism, gene expression of the CYP450 family (CYP1A1, CYP2A6, CYP2B6, CYP3A4 and CYP3A5), the inflammatory markers COX-2 and 5-LOX, the xenobiotic metabolizer NAT2, and the MRP2 transporter was analysed in a coculture system of Caco-2 and HepG2 cells. It should be firstly noted that gene expression was not affected by the added solvent (DMSO) as there were no statistically significant differences between the blank (medium alone) and DMSO treatments, with a p-value of 0.6882 for the Caco-2 cells and 0.3128 for the HepG2 cells. Hence, all relative gene expression ratios were calculated by referring to the Cp-values from the control treatments that were exposed to the same DMSO concentration as the OTA treatments. 
Discussion
The first OTA evaluation conducted by the IARC (IARC, 1983) concluded that the evidence for nephrotoxicity, teratogenicity and carcinogenicity was insufficient to classify OTA as a carcinogenic compound to humans. Later, the toxic potential of OTA was greatly supported. However, the toxicological mechanism of this mycotoxin is still unclear, and a controversy exists about its genotoxic or epigenetic mode of action (IARC, 1993; Marin-Kuan et al., 2006) . Kinetics studies in animal species showed that OTA is slowly distributed to peripheral compartments (Galtier et al. 1979 , Sreemannarayana et al., 1988 Li et al., 1997) , and that the molecule could be reabsorbed and redistributed Fuchs and Hult, 1992; Sreemannarayana et al., 1988) . Several 14 studies have reported a prolonged half-life of the toxin and a secondary reintroduction to the intestine through the enterohepatic circulation, since the biliary excretion of OTA is very efficient, making the presence of OTA in the intestine prolonged in time (Li et al., 1997; Ringot et al., 2006) . OTA toxicity has been attributed to its isocoumarin moiety, and it is well known that OTA is inactivated/bioactivated by cytochrome P450 enzymes (Faucet-Marquis et al., 2006; Malaveille et al., 1991; Ringot et al., 2006; Tozlovanu et al., 2012) .
In order to observe the change induced in vitro by OTA over time, and taking into account the high half-life and the enterohepatic circulation of OTA observed in in vivo studies, in the present study the toxicity and the effect on gene expression of OTA were assayed at three times of exposure (3, 12 and 24 h). To carry out our study we have used a co-culture system with Caco-2 and HepG2 cells that mimics the absorption in the intestine (through of the porous membrane) and the hepatic metabolism.
In this system, the effect of OTA on the expression of cytochrome genes, the NAT2 gene (involved in phase II of metabolism), two inflammation markers (COX-2 and 5-LOX) and the MRP2 gene (encoding for a transporter of xenobiotics outward during absorption and in liver metabolism) was evaluated.
The cell viability results from the MTS assay showed that only 24 h of OTA exposure caused a decrease in viability. Our data agree with other studies which also described high viability percentages (low cytotoxicity values) in treatments with <100 µM OTA for 24 h or less (Berger et al., 2003; Maresca et al., 2001; McLaughlin et al., 2004; Sergent et al., 2005; Ramyaa et al., 2013 Zheng et al. (2013) , who found that 37.27 µM OTA for 24 h caused 50% cytotoxicity in HepG2 cells.
In addition, OTA cytotoxicity was also determined by evaluating membrane integrity in
Caco-2 cells. Our results showed that OTA caused damage in physiological barrier functions through a paracellular transport that decreases TEER. This mechanism involves substances up to 10 but not 20 kDa, as OTA, and the elimination of tight junction proteins (Claudin 3 and 4). Conversely, good membrane homeostasis is related to high TEER and the presence of tight junctions (Kiatsurayanon et al., 2014; Yuki et al., 2007) .
In Caco-2 cells, membrane integrity (measured by TEER) and cell viability (from the MTS assay) were closely related. In this study, we found a decrease of 60% in TEER by Berger et al. (2003) , using 10 µM OTA for 3 h, or in our study during the 3 h treatment.
To further investigate the effect of OTA on the xenobiotic transporter gene (MRP2), the metabolic enzymes (cytochrome P450: CYP1A1, CYP2A6, CYP2B6, CYP3A4 and CYP3A5; and NAT2), and the inflammatory response genes (COX-2 and 5-LOX), a gene expression analysis was performed using Caco-2 and HepG2 cells. Our data showed a down-regulation of MRP2 expression, indicating an impairment of the secretion of OTA.
The MRP2 transporter is a key primary active transporter involved in anionic conjugate and drug extrusion from the human liver but which is also present in the apical membranes of enterocytes, kidney-proximal tubules and other cells (Jedlitschky et al., 2006) . In rat, it has been observed that OTA was excreted 15% less in the proximal tubules of the kidney, while the proximal tubular transport of amino acids was not impaired by OTA (Gekle and Silbernagl, 1994) . Therefore, the down-regulation of MRP2 and the TEER decrease found in this study could be the mechanism through which OTA reaches high percentages of bioavailability in vivo. In this way, the OTA exposure in hepatic cells would be magnified, contributing to the hepatotoxicity. Considering the nephrotoxic potential of OTA, the down-regulation of the MRP2 gene may also have a major impact on the proximal tubule, leading to a decreased capacity to eliminate OTA.
However, further studies are needed on the OTA transporter mechanism to corroborate this hypothesis.
Concerning the expression of the CYP450 genes, these genes were down-regulated and up-regulated by OTA in Caco-2 and HepG2 cells, respectively. The induction of CYP450 genes in the xenobiotic response has been previously studied, and the mechanism is 17 now largely understood. Nevertheless, the mechanism involved in CYP450 suppression still remains to be clarified. The CYP450 genes show a similar response because they often involve activation of common cytosolic or nuclear receptors, including the aromatic hydrocarbon receptor, the constitutive androstane receptor, the pregnane X receptor, and the peroxisome proliferator-activated receptor-alpha (Honkakoski and Negishi, 2000) .
The effect of polycyclic and halogenated aromatic hydrocarbons is used as model for in the liver and kidney from male Fisher-344 rats. In Dark Agouti rats of both sexes, only
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CYP3A4 expression was detected in male livers after OTA treatment, and CYP1A expression was higher than CYP2A (Pfohl-Leszkowicz et al., 1998) , as in our in vitro assay.
With regard to CYP2B6, our results at 5-45 µM OTA for 3 h showed a down-regulation up to 8-fold in both cell types, but an increase was detected at 12 h in HepG2 cells. In contrast with the up-regulation of CYP2B6 in primary human hepatocytes, the level of CYP2B6 mRNA was higher (22.5-6.8-fold induction) than the mRNA level of other cytochromes after treatment at 10 μM (Ayed-Boussema et al., 2012) .
NAT2 gene, encoding for an inducible and xenobiotic metabolizing enzyme of phase II, had lower expression in Caco-2 cells than in HepG2 cells, in line with results described in the literature (Husain et al., 2007) . In our study, the highest effect on NAT-2 expression was detected after 24 h of OTA exposure, where the NAT2 gene was strongly modulated by OTA. It is noteworthy that expression of the NAT2 gene regarding OTA exposure has not been studied previously, although Lebrun et al. (2002) reported a high correlation between NAT2 polymorphism and DNA damage in an in vitro culture of OTA-exposed human urothelial cells. OTA intake has been linked to a chronic tubulointerstitial renal disease (chronic nephropathy) frequently accompanied by urothelial cell carcinomas of the urinary tract, although this relationship has not been proven completely (Batuman, 2006; Grollman and Jelacovic, 2007; Reddy and Bhoola, 2010) . Besides, a very strong epidemiological association has been established between the NAT2 genotypes and a variable risk of urinary bladder cancer caused by arylamines, possibly due to an impaired detoxification of carcinogenic metabolites in the liver (Hein et al., 2000; Husain et al., 2007) .
To investigate modulation of the inflammatory response induced by OTA, the expression of COX-2 and 5-LOX genes was determined. We have detected a rapid change from 3 to 12 h in cellular 5-LOX expression in Caco-2 cells, while in HepG2 cells, the changes were over time. The COX-2 gene was down-and up-regulated in Caco-2 and HepG2 cells, respectively. Changes in the regulation pattern could be due to an adaptive response (Chung et al., 2008; Morgan, 2001 ).
Changes in the regulation pattern could be due to an adaptive response for controlling the generation of ROS, as observed by Chung et al. (2008) in A549 human lung carcinoma cells treated with acenaphthenequinone. In this sense, the oxidative stress caused by OTA has been widely described in the literature as ROS generation (Ramyaa et al. 2013) , DNA damage (González-Arias et al., 2014; Ramyaa et al., 2013) and histopathological changes in the liver and kidney (Aydin et al., 2003) . Recently, Kumar et al. (2013) and Ramyaa et al. (2013) investigated the relationship between OTA exposure and COX-2 expression and obtained similar results as our study. Thus, in mouse (with a single dermal application of OTA), an early inflammatory response, demonstrated by COX-2 expression, increased after 6 h of OTA exposure and a maximum was observed at 18 h (Kumar et al., 2013) . Ramyaa et al. (2013) observed that COX-2 expression increased after 15 h exposure to OTA in HepG2 cells, but, curiously, it was inhibited after 24 h. In the present study, we have not studied NF-κB expression, but several studies indicate that the expression of COX-2 and 5-LOX is related to NF-κB, the main transcription factor that regulates the proinflammatory response (González-Périz and Clàira, 2007; Chung et al., 2008) . Nowadays, few studies have investigated the effect of OTA on the COX-2 and 5-LOX genes, or on their proteins (Ramyaa et al., 2014; Kumar 20 et al., 2013; Ferrante et al., 2006 and 2008) , and a possible mechanism of downregulation has not been established. Some authors have observed an inhibition of nuclear factor-kappa B (NF-κB) expression and an increase in heat shock protein 72 expression, both in in vivo and in vitro studies, after OTA exposure, leading the downregulation of proinflammatory mediators (Ferrante et al., 2006 , Ramyaa et al., 2014 . Our results support previous studies which described a pro-inflammatory role of OTA but further studies are necessary.
Conclusion
The use of cell lines is an alternative to overcome the disadvantages of the primary cell lines, as their scarce availability, limited growth potential, short lifespan, differences between batches, and their susceptibility to undergo early and variable phenotypic alterations. Additionally, basal gene expression in freshly isolated primary human cells is also different between culture passages (Hart et al., 2010) . The proper use of data published in literature can support the results and the focus of our study. However, depending on the human cell line or primary cell line used, and its ability to express or induce the genes, comparison of results can be difficult. In addition, an increase in the mRNA level in cells or liver tissues does not necessarily mean that similar results occur at protein level (Hart et al., 2010; Sun et al., 2002) . It is known that different processes are implicated in OTA metabolism and toxicity. Direct or indirect DNA damage, as well as epigenetic mechanisms, are responsible for the tumour promotion phase during carcinogenesis, and all of these mechanisms have been related to OTA toxicity at noncytotoxic doses during long-term exposure (Gonzalez-Arias et al., 2014; Horvath et al., 21 2002; Qi et al., 2014) . Conversely, histological changes in the liver, kidney and skin have been detected after high doses of OTA exposure (Kamp et al., 2005; Kumar et al., 2013; Palabiyik et al., 2013; Qi et al., 2014) . The co-culture system that mimics the passage through the intestine as a first barrier allowed us to obtain results that could be more similar than those recorded in in vivo studies. The data generated from the gene expression analysis in enterocytes and hepatocytes exposed to OTA suggest a different mechanism of action in intestinal epithelium during absorption than in OTA metabolism in the liver. 
